CRT-DL scientist authors high impact paper

Laura Rosenberg, a Senior Scientist at CRT Discovery Laboratories (CRT-DL), is first author of a study published on December 16th in Science Translational Medicine. The study, conducted whilst Laura was a senior research associate at Scripps Florida, provides novel insight into the role of CK1δ in human breast cancer and identifies this kinase as a potential therapeutic target in a subset of hard-to-treat cancers with activated WNT/β-catenin signalling.

View the paper here

Read the press release here